[HTML] nih.gov

[HTML][HTML] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Tackling problematic polypharmacy requires tailoring the use of medicines
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …
被引用次数：24 相关文章
[PDF] academia.edu

[PDF][PDF] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk, K Mahtani… - Health Technology …, 2022 - academia.edu
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the
TAILOR evidence synthesis Page 1 Journals Library DOI 10.3310/AAFO2475 Deprescribing …
[HTML] nih.gov

[HTML][HTML] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk, K Mahtani, G Wong… - 2022 - ncbi.nlm.nih.gov
Background: Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …

[引用][C] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - journalslibrary.nihr.ac.uk
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …
[HTML] europepmc.org

[HTML][HTML] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - europepmc.org
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk, K Mahtani… - Health Technology …, 2022 - ora.ox.ac.uk
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk… - Health technology …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - wrap.warwick.ac.uk
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis

J Reeve, M Maden, R Hill, A Turk, K Mahtani, G Wong… - 2022 - pearl.plymouth.ac.uk
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …
[HTML] europepmc.org

[HTML][HTML] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.

J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - europepmc.org
Background Tackling problematic polypharmacy requires tailoring the use of medicines to
individual needs and circumstances. This may involve stopping medicines (deprescribing) …